Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-05-30 20:55:53 UTC |
---|
HMDB ID | HMDB0000206 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | N6-Acetyl-L-lysine |
---|
Description | N-epsilon-Acetyl-L-lysine also known as Nepsilon-Acetyllysine or N6-Acetyllysine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at one of its nitrogen atoms. N-epsilon-Acetyl-L-lysine can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-epsilon-Acetyl-L-lysine is a biologically available sidechain, N-capped form of the proteinogenic alpha amino acid L-lysine. Unlike L-lysine, acetylated lysine derivatives such as N-epsilon-Acetyl-L-lysine are zwitterionic compounds. These are molecules that contains an equal number of positively- and negatively-charged functional groups. N-epsilon-Acetyl-L-lysine is found naturally in eukaryotes ranging from yeast to plants to humans. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins (often histones) by specific hydrolases. N-epsilon-Acetyl-L-lysine can be biosynthesized from L-lysine and acetyl-CoA via the enzyme known as Lysine N-acetyltransferase. Post-translational lysine-acetylation is one of two major modifications of lysine residues in various proteins - either N-terminal or N-alpha acetylation or N6 (sidechain) acetylation. Side-chain acetylation of specific lysine residues in the N-terminal domains of core histones is a biochemical marker of active genes. Acetylation is now known to play a major role in eukaryotic transcription. Specifically, acetyltransferase enzymes that act on particular lysine side chains of histones and other proteins are intimately involved in transcriptional activation. By modifying chromatin proteins and transcription-related factors, these acetylases are believed to regulate the transcription of many genes. The best-characterized mechanism is acetylation, catalyzed by histone acetyltransferase (HAT) enzymes. HATs function enzymatically by transferring an acetyl group from acetyl-coenzyme A (acetyl-CoA) to the amino group of certain lysine side chains within a histone's basic N-terminal tail region. Within a histone octamer, these regions extend out from the associated globular domains, and in the context of a nucleosome, they are believed to bind the DNA through charge interactions (positively charged histone tails associated with negatively charged DNA) or mediate interactions between nucleosomes. Lysine acetylation, which neutralizes part of a tail region's positive charge, is postulated to weaken histone-DNA or nucleosome-nucleosome interactions and/or signal a conformational change, thereby destabilizing nucleosome structure or arrangement and giving other nuclear factors, such as the transcription complex, more access to a genetic locus. In agreement with this is the fact that acetylated chromatin has long been associated with states of transcriptional activation. Specific recognition of N6-acetyl-L-lysine is a conserved function of all bromodomains found in different proteins, recognized as an emerging intracellular signalling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (PMID: 9169194 , 10827952 , 17340003 , 16247734 , 9478947 , 10839822 ). N-acetylated amino acids, such as N-epsilon-Acetyl-L-lysine can be released by an N-acylpeptide hydrolase from histones going through proteolytic degradation (PMID: 16465618 ). Many N-acetylamino acids are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986 ; PMID: 20613759 ). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557 ). |
---|
Structure | CC(=O)NCCCC[C@H](N)C(O)=O InChI=1S/C8H16N2O3/c1-6(11)10-5-3-2-4-7(9)8(12)13/h7H,2-5,9H2,1H3,(H,10,11)(H,12,13)/t7-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(2S)-6-(Acetylamino)-2-aminohexanoic acid | ChEBI | N(6)-ACETYLLYSINE | ChEBI | N(zeta)-Acetyllysine | ChEBI | N-epsilon-Acetyl-L-lysine | ChEBI | N-Epsilon-Acetyllysine | ChEBI | N(epsilon)-Acetyl-L-lysine | ChEBI | N(zeta)-Acetyl-L-lysine | ChEBI | (2S)-6-(Acetylamino)-2-aminohexanoate | Generator | N(Z)-Acetyllysine | Generator | N(Ζ)-acetyllysine | Generator | N(Z)-Acetyl-L-lysine | Generator | N(Ζ)-acetyl-L-lysine | Generator | e-Acetyl-L-lysine | HMDB | e-N-Acetyl-L-lysine | HMDB | e-N-Acetyllysine | HMDB | epsilon-Acetyl-L-lysine | HMDB | epsilon-N-Acetyl-L-lysine | HMDB | epsilon-N-Acetyllysine | HMDB | L-e-N-Acetyllysine | HMDB | L-epsilon-N-Acetyllysine | HMDB | N-e-Acetyl-L-lysine | HMDB | N-e-Acetyllysine | HMDB | N6-Acetyllysine | HMDB | Ne-acetyl-L-lysine | HMDB | Ne-acetyllysine | HMDB | Omega-N-acetyl-L-lysine | HMDB | W-N-Acetyl-L-lysine | HMDB | N(6)-Acetyllsine | HMDB | Omega-acetyllsine | HMDB | (2S)-6-Acetamido-2-aminohexanoic acid | HMDB | 6-Acetamido-2-aminohexanoic acid | HMDB | L-Ε-N-acetyllysine | HMDB | Nepsilon-acetyl-L-lysine | HMDB | Nepsilon-acetyllysine | HMDB | Nε-acetyl-L-lysine | HMDB | Nε-acetyllysine | HMDB | Ε-acetyl-L-lysine | HMDB | Ε-N-acetyl-L-lysine | HMDB | Ε-N-acetyllysine | HMDB | Ω-N-acetyl-L-lysine | HMDB | N6-Acetyl-L-lysine | ChEBI |
|
---|
Chemical Formula | C8H16N2O3 |
---|
Average Molecular Weight | 188.2242 |
---|
Monoisotopic Molecular Weight | 188.116092388 |
---|
IUPAC Name | (2S)-2-amino-6-acetamidohexanoic acid |
---|
Traditional Name | N6-acetyllysine |
---|
CAS Registry Number | 692-04-6 |
---|
SMILES | CC(=O)NCCCC[C@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C8H16N2O3/c1-6(11)10-5-3-2-4-7(9)8(12)13/h7H,2-5,9H2,1H3,(H,10,11)(H,12,13)/t7-/m0/s1 |
---|
InChI Key | DTERQYGMUDWYAZ-ZETCQYMHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Medium-chain fatty acid
- Amino fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Primary aliphatic amine
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N6-Acetyl-L-lysine,1TMS,isomer #1 | CC(=O)NCCCC[C@H](N)C(=O)O[Si](C)(C)C | 1829.2 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,1TMS,isomer #2 | CC(=O)NCCCC[C@H](N[Si](C)(C)C)C(=O)O | 1903.0 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,1TMS,isomer #3 | CC(=O)N(CCCC[C@H](N)C(=O)O)[Si](C)(C)C | 1877.2 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1928.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1922.8 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2389.5 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1821.4 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1946.0 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2687.9 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O)[Si](C)(C)C | 1945.8 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O)[Si](C)(C)C | 1942.8 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O)[Si](C)(C)C | 2495.9 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2070.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1967.0 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2560.6 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1920.1 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1993.5 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2125.8 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2088.7 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2032.4 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2223.3 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2048.3 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2060.4 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2282.7 | Standard polar | 33892256 | N6-Acetyl-L-lysine,4TMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2083.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,4TMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2104.0 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,4TMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2041.3 | Standard polar | 33892256 | N6-Acetyl-L-lysine,1TBDMS,isomer #1 | CC(=O)NCCCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 2103.5 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,1TBDMS,isomer #2 | CC(=O)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 2168.1 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,1TBDMS,isomer #3 | CC(=O)N(CCCC[C@H](N)C(=O)O)[Si](C)(C)C(C)(C)C | 2090.8 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2410.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2341.9 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #1 | CC(=O)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2481.0 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2291.7 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2373.5 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #2 | CC(=O)N(CCCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2713.8 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C | 2417.2 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C | 2369.6 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #3 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C | 2569.5 | Standard polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2534.8 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2381.5 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,2TBDMS,isomer #4 | CC(=O)NCCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2580.1 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2606.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2589.1 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #1 | CC(=O)N(CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2472.3 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2769.3 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2626.4 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #2 | CC(=O)NCCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2486.9 | Standard polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2703.9 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2645.1 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,3TBDMS,isomer #3 | CC(=O)N(CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2546.8 | Standard polar | 33892256 | N6-Acetyl-L-lysine,4TBDMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2947.8 | Semi standard non polar | 33892256 | N6-Acetyl-L-lysine,4TBDMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2847.3 | Standard non polar | 33892256 | N6-Acetyl-L-lysine,4TBDMS,isomer #1 | CC(=O)N(CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2490.3 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (3 TMS) | splash10-0002-9610000000-6e30cfdb2a70cc49f983 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (Non-derivatized) | splash10-0002-9610000000-6e30cfdb2a70cc49f983 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N6-Acetyl-L-lysine GC-EI-TOF (Non-derivatized) | splash10-004i-1900000000-e36d5532f4f0ed8ec34f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N6-Acetyl-L-lysine GC-EI-TOF (Non-derivatized) | splash10-0002-9500000000-266c8b0fce84c71553b2 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (Non-derivatized) - 70eV, Positive | splash10-006x-9200000000-a186b34425c93ea31a66 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9110000000-255e47c2dfcdf6b61403 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N6-Acetyl-L-lysine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004r-1900000000-4745f7cfa9eaaef208ad | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-001i-9000000000-635805826359aa05ec7c | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-001i-9000000000-8857489c6ac957c71a5d | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-000i-0900000000-39f91157038523017046 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-000j-0900000000-183e1f50c20603f14c03 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0002-1900000000-da02d0f8bd73b5b96b46 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0a4j-9400000000-8531cdbb4e8108dbec95 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0a4l-9000000000-94d72f2c644db8c0b5cd | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-000i-0900000000-c6ff005564503774a853 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-004i-3900000000-dffc604f608a010e711e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-001i-9000000000-d6bc330de42890c4c091 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-001i-9000000000-8d68337bf7a8db380cd7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-001i-9000000000-1400569a447d5f66c3a8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , negative-QTOF | splash10-000i-0900000000-39f91157038523017046 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , negative-QTOF | splash10-000j-0900000000-183e1f50c20603f14c03 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , negative-QTOF | splash10-0002-1900000000-da02d0f8bd73b5b96b46 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , negative-QTOF | splash10-0a4j-9400000000-8531cdbb4e8108dbec95 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , negative-QTOF | splash10-0a4l-9000000000-94d72f2c644db8c0b5cd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N6-Acetyl-L-lysine LC-ESI-QQ , positive-QTOF | splash10-000i-0900000000-c6ff005564503774a853 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 10V, Positive-QTOF | splash10-0077-0900000000-e0d9659d3d504e9c8d81 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 20V, Positive-QTOF | splash10-0ued-3900000000-ae84e0c568d22d7c62fb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 40V, Positive-QTOF | splash10-001i-9100000000-848f804e26f5a4edfcfb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 10V, Negative-QTOF | splash10-000i-0900000000-545e3c760ee61913f301 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 20V, Negative-QTOF | splash10-05p2-3900000000-3a6e9f0c90d936bd6ae8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N6-Acetyl-L-lysine 40V, Negative-QTOF | splash10-052f-9000000000-33c2ede158e490bcc70f | 2017-09-01 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.036-2.828 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 9.318 +/- 4.75 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 1.14 (0.90-1.49) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Attachment loss | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Periodontal Probing Depth | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Supragingival Plaque | | details | Urine | Detected and Quantified | 10.141 +/- 3.949 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Attachment loss |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Periodontal Probing Depth |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Supragingival Plaque |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | - 114500 (Colorectal cancer)
- 610247 (Eosinophilic esophagitis)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB000476 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 83801 |
---|
KEGG Compound ID | C02727 |
---|
BioCyc ID | CPD-567 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Acetyllysine |
---|
METLIN ID | 5216 |
---|
PubChem Compound | 92832 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17752 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1266461 |
---|
References |
---|
Synthesis Reference | Benoiton, Leo; Leclerc, Jean. An improved synthesis of e-N-acetyl-L-lysine and similar compounds. Canadian Journal of Chemistry (1965), 43(4), 991-3. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Sass JO, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M, Loges NT, Schweitzer-Krantz S, Moebus R, Weiler P, Kispert A, Superti-Furga A, Wevers RA, Omran H: Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet. 2006 Mar;78(3):401-9. Epub 2006 Jan 18. [PubMed:16465618 ]
- Jacobson RH, Ladurner AG, King DS, Tjian R: Structure and function of a human TAFII250 double bromodomain module. Science. 2000 May 26;288(5470):1422-5. [PubMed:10827952 ]
- Armstrong MD, Robinow M: A case of hyperlysinemia: biochemical and clinical observations. Pediatrics. 1967 Apr;39(4):546-54. [PubMed:6022933 ]
- Crane-Robinson C, Hebbes TR, Clayton AL, Thorne AW: Chromosomal mapping of core histone acetylation by immunoselection. Methods. 1997 May;12(1):48-56. [PubMed:9169194 ]
- Jamonnak N, Fatkins DG, Wei L, Zheng W: N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine. Org Biomol Chem. 2007 Mar 21;5(6):892-6. Epub 2007 Feb 5. [PubMed:17340003 ]
- Iwabata H, Yoshida M, Komatsu Y: Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics. 2005 Dec;5(18):4653-64. [PubMed:16247734 ]
- Hazen SL, d'Avignon A, Anderson MM, Hsu FF, Heinecke JW: Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J Biol Chem. 1998 Feb 27;273(9):4997-5005. [PubMed:9478947 ]
- Sterner DE, Berger SL: Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev. 2000 Jun;64(2):435-59. [PubMed:10839822 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Tanaka H, Sirich TL, Plummer NS, Weaver DS, Meyer TW: An Enlarged Profile of Uremic Solutes. PLoS One. 2015 Aug 28;10(8):e0135657. doi: 10.1371/journal.pone.0135657. eCollection 2015. [PubMed:26317986 ]
- Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T: Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res. 2010 Sep;33(9):944-52. doi: 10.1038/hr.2010.113. Epub 2010 Jul 8. [PubMed:20613759 ]
- Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J: A bench to bedside view of uremic toxins. J Am Soc Nephrol. 2008 May;19(5):863-70. doi: 10.1681/ASN.2007121377. Epub 2008 Feb 20. [PubMed:18287557 ]
|
---|